SFCM
LRMR icon

Seven Fleet Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Seven Fleet Capital Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704K Sell
230,921
-25,664
-10% -$102K 0.12% 65
2026
Q1 		$1.15M Buy
+256,585
New +$1.03M 0.36% 55

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Seven Fleet Capital Management's LRMR Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Larimar Therapeutics (LRMR) stake by 10% in Q2 2026, selling an estimated $102K and leaving 230,921 shares worth $704K. The position accounts for 0.12% of the portfolio, ranked #65.

Seven Fleet Capital Management first reported a position in LRMR in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.15M in Q1 2026. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Seven Fleet Capital Management held 230,921 shares of Larimar Therapeutics worth $704K as of Q2 2026.
  • Seven Fleet Capital Management sold 25,664 Larimar Therapeutics shares in Q2 2026, an estimated $102K.
  • Larimar Therapeutics made up 0.12% of Seven Fleet Capital Management's portfolio in Q2 2026, its #65 holding.
  • Seven Fleet Capital Management first reported a position in Larimar Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Larimar Therapeutics position peaked at $1.15M in Q1 2026.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.